In diabetic neuropathy, palmatine decreased phosphorylation of the ERK1/2 pathway, which contributed to a reduction in the expression of P2X7, a receptor with an important role in the development of pain and depression [30]. Here, MAPK3 is linked to depressive symptom measurement.